Alert: Major Price Decline (8/2/24)-Atara Biotherapeutics Inc (NASDAQ: ATRA).

out_logo_500#72142.jpg

On 8/2/24, Atara Biotherapeutics Inc (NASDAQ: ATRA) stock suffered a major decline of -12.8%, closing at $9.07. However, this decline was accompanied by unusually low trading volume at 56% of normal. Relative to the market the stock has been extremely weak over the last nine months and has declined -7.1% during the last week.

out_mm#72142.jpg

Current PriceTarget Research Rating

With future capital returns forecasted to be in line with the cost of capital, ATRA is expected to continue to be Value Creation neutral.

Atara Biotherapeutics is currently unrated.

Rating Review

The stock is currently unrated.

Be the first to comment

Leave a Reply

Your email address will not be published.


*